GlaxoSmithKline, Amicus Expand Drug Collaboration

Amicus Therapeutics and GlaxoSmithKline said they are expanding their collaboration to develop a treatment for Fabry disease, with GSK agreeing to buy a larger stake in the smaller pharmaceutical company.
Fox Business